tiprankstipranks
Advertisement
Advertisement
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
PremiumRatingsMiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
2M ago
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
Premium
Company Announcements
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
2M ago
INKT Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
2M ago
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
PremiumRatingsMiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
2M ago
Why Is MiNK Therapeutics Stock (INKT) Up Today?
Premium
Market News
Why Is MiNK Therapeutics Stock (INKT) Up Today?
2M ago
MiNK Therapeutics announces strategic collaboration with C-Further
Premium
The Fly
MiNK Therapeutics announces strategic collaboration with C-Further
2M ago
MiNK Therapeutics Advances iNKT Platform in Q3 2025
PremiumCompany AnnouncementsMiNK Therapeutics Advances iNKT Platform in Q3 2025
6M ago
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
Premium
Company Announcements
MiNK Therapeutics Earnings Call: Positive Sentiment and Promising Future
6M ago
MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
Premium
Ratings
MiNK Therapeutics: Advancing Clinical Trials and Strategic Partnerships to Address GvHD and Pulmonary Diseases
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100